Dr Ryan Keith Miyamoto, MD | |
1717 N E St, 430, Pensacola, FL 32501-6339 | |
(850) 437-8711 | |
Not Available |
Full Name | Dr Ryan Keith Miyamoto |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 20 Years |
Location | 1717 N E St, Pensacola, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245415454 | NPI | - | NPPES |
016158700 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 4301097056 (Michigan) | Secondary |
208800000X | Urology | ME126100 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baptist Home Health Care | Pensacola, FL | Home health agency |
Baptist Hospital | Pensacola, FL | Hospital |
Gulf Breeze Hospital | Gulf breeze, FL | Hospital |
Sacred Heart Hospital | Pensacola, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baptist Medical Group Llc | 9638215734 | 220 |
News Archive
HealthWarehouse.com, Inc., a leading VIPPS-accredited, retail mail-order pharmacy, announced today the launch of its pre-order program to enable consumers immediate access to Atorvastatin (Generic LipitorĀ®) on Dec. 5. HealthWarehouse will offer the medication at up to 50 percent less than the branded versions from retail pharmacies.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
Forest Laboratories, Inc. and Almirall, S.A. announced today that the U.S. Food and Drug Administration (FDA) will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for aclidinium bromide, a new long-acting antimuscarinic for the maintenance treatment of Chronic Obstructive Pulmonary Disease.
Docosahexaenoic acid (DHA), an omega-3 fatty acid, is essential for the growth and development of infants' brains. Very premature infants may be deficient in DHA because they miss out on the third trimester in utero when the fatty acid accumulates in tissues. In addition, their gastrointestinal system is immature, and health problems often increase the risk of malnutrition.
New research has shown that in older adults (65 and older), being an occupant in an automobile during a motor vehicle accident may lead to heart failure or stroke, as compared to pedestrians who are involved in motor vehicle accidents.
› Verified 9 days ago
Entity Name | Baptist Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376779892 PECOS PAC ID: 9638215734 Enrollment ID: O20091002000436 |
News Archive
HealthWarehouse.com, Inc., a leading VIPPS-accredited, retail mail-order pharmacy, announced today the launch of its pre-order program to enable consumers immediate access to Atorvastatin (Generic LipitorĀ®) on Dec. 5. HealthWarehouse will offer the medication at up to 50 percent less than the branded versions from retail pharmacies.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
Forest Laboratories, Inc. and Almirall, S.A. announced today that the U.S. Food and Drug Administration (FDA) will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for aclidinium bromide, a new long-acting antimuscarinic for the maintenance treatment of Chronic Obstructive Pulmonary Disease.
Docosahexaenoic acid (DHA), an omega-3 fatty acid, is essential for the growth and development of infants' brains. Very premature infants may be deficient in DHA because they miss out on the third trimester in utero when the fatty acid accumulates in tissues. In addition, their gastrointestinal system is immature, and health problems often increase the risk of malnutrition.
New research has shown that in older adults (65 and older), being an occupant in an automobile during a motor vehicle accident may lead to heart failure or stroke, as compared to pedestrians who are involved in motor vehicle accidents.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ryan Keith Miyamoto, MD 1717 N E St, 430, Pensacola, FL 32501-6339 Ph: (850) 437-8711 | Dr Ryan Keith Miyamoto, MD 1717 N E St, 430, Pensacola, FL 32501-6339 Ph: (850) 437-8711 |
News Archive
HealthWarehouse.com, Inc., a leading VIPPS-accredited, retail mail-order pharmacy, announced today the launch of its pre-order program to enable consumers immediate access to Atorvastatin (Generic LipitorĀ®) on Dec. 5. HealthWarehouse will offer the medication at up to 50 percent less than the branded versions from retail pharmacies.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
Forest Laboratories, Inc. and Almirall, S.A. announced today that the U.S. Food and Drug Administration (FDA) will require a three-month extension to complete its review of the data supporting the New Drug Application (NDA) for aclidinium bromide, a new long-acting antimuscarinic for the maintenance treatment of Chronic Obstructive Pulmonary Disease.
Docosahexaenoic acid (DHA), an omega-3 fatty acid, is essential for the growth and development of infants' brains. Very premature infants may be deficient in DHA because they miss out on the third trimester in utero when the fatty acid accumulates in tissues. In addition, their gastrointestinal system is immature, and health problems often increase the risk of malnutrition.
New research has shown that in older adults (65 and older), being an occupant in an automobile during a motor vehicle accident may lead to heart failure or stroke, as compared to pedestrians who are involved in motor vehicle accidents.
› Verified 9 days ago
Ashley B. King, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 | |
Dr. Alexander Liu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 Fax: 850-434-2647 | |
Dr. Kevin Gerald Mahaffey, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6000 W Highway 98, Naval Hospital Urology, Pensacola, FL 32512 Phone: 850-505-6485 | |
Dr. Anthony L Doerr, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 8333 N Davis Hwy, Urology Dept, Pensacola, FL 32514 Phone: 850-474-8398 Fax: 850-969-2962 | |
Robert A. Mevorach, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5153 N 9th Ave, Pensacola, FL 32504 Phone: 850-505-4700 | |
Dr. Spencer Land, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1549 Airport Blvd Ste 200f, Pensacola, FL 32504 Phone: 850-416-1950 Fax: 850-416-1951 |